Home / Lifestyle / Health & Fitness / Article / FDA expands use of HPV vaccine for adults aged 27-45 years

FDA expands use of HPV vaccine for adults aged 27-45 years

The vaccine Gardasil 9 covers nine HPV types that are responsible for certain cancers and diseases

  • WhatsAppBookmarkBookmark
Listen to this article :
Representational Image

Representational Image

The US Food and Drug Administration (FDA) has approved the use of Human Papillomavirus (HPV) vaccine, which prevents cervical cancer and other malignancies, for men and women aged 27-45 years.

The vaccine Gardasil 9 covers nine HPV types that are responsible for certain cancers and diseases. It was earlier approved for use in males and females aged 9 through 26 years.

Read Next Story
Aspirin can reduce liver cancer risk: Study›

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All